Seguir
Dan Peer
Dan Peer
Prof. of NanoMedicine and Immunology, Tel Aviv University
Dirección de correo verificada de post.tau.ac.il
Título
Citado por
Citado por
Año
Nanocarriers as an emerging platform for cancer therapy
D Peer, JM Karp, S Hong, OC Farokhzad, R Margalit, R Langer
Nano-enabled medical applications, 61-91, 2020
96242020
Progress and challenges towards targeted delivery of cancer therapeutics
D Rosenblum, N Joshi, W Tao, JM Karp, D Peer
Nature communications 9 (1), 1410, 2018
17642018
Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target
D Peer, EJ Park, Y Morishita, CV Carman, M Shimaoka
Science 319 (5863), 627-630, 2008
5802008
Nanoparticle hydrophobicity dictates immune response
DF Moyano, M Goldsmith, DJ Solfiell, D Landesman-Milo, OR Miranda, ...
Journal of the American Chemical Society 134 (9), 3965-3967, 2012
4782012
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
R Kedmi, N Ben-Arie, D Peer
Biomaterials 31 (26), 6867-6875, 2010
4652010
Polysaccharides as building blocks for nanotherapeutics
S Mizrahy, D Peer
Chemical Society Reviews 41 (7), 2623-2640, 2012
4322012
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
D Peer, P Zhu, CV Carman, J Lieberman, M Shimaoka
Proceedings of the National Academy of Sciences 104 (10), 4095-4100, 2007
3332007
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
D Rosenblum, A Gutkin, R Kedmi, S Ramishetti, N Veiga, AM Jacobi, ...
Science advances 6 (47), eabc9450, 2020
3202020
Nanoparticles for imaging, sensing, and therapeutic intervention
LK Bogart, G Pourroy, CJ Murphy, V Puntes, T Pellegrino, D Rosenblum, ...
ACS nano 8 (4), 3107-3122, 2014
3182014
Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions
TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ...
ACS nano 11 (1), 12-18, 2017
3082017
Loading mitomycin C inside long circulating hyaluronan targeted nano‐liposomes increases its antitumor activity in three mice tumor models
D Peer, R Margalit
International Journal of Cancer 108 (5), 780-789, 2004
2872004
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models
D Peer, R Margalit
Neoplasia (New York, NY) 6 (4), 343, 2004
2622004
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice
SS Kim, D Peer, P Kumar, S Subramanya, H Wu, D Asthana, K Habiro, ...
Molecular therapy 18 (2), 370-376, 2010
2482010
Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response
S Mizrahy, SR Raz, M Hasgaard, H Liu, N Soffer-Tsur, K Cohen, R Dvash, ...
Journal of controlled release 156 (2), 231-238, 2011
2452011
A modular platform for targeted RNAi therapeutics
R Kedmi, N Veiga, S Ramishetti, M Goldsmith, D Rosenblum, N Dammes, ...
Nature nanotechnology 13 (3), 214-219, 2018
2242018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
N Veiga, M Goldsmith, Y Granot, D Rosenblum, N Dammes, R Kedmi, ...
Nature communications 9 (1), 4493, 2018
2222018
RNAi-based nanomedicines for targeted personalized therapy
A Daka, D Peer
Advanced drug delivery reviews 64 (13), 1508-1521, 2012
1932012
Special delivery: targeted therapy with small RNAs
D Peer, J Lieberman
Gene therapy 18 (12), 1127-1133, 2011
1832011
Next-generation lipids in RNA interference therapeutics
S Rietwyk, D Peer
ACS nano 11 (8), 7572-7586, 2017
1782017
Paving the road for RNA therapeutics
N Dammes, D Peer
Trends in pharmacological sciences 41 (10), 755-775, 2020
1762020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20